Physicians' Academy for Cardiovascular Education

Endothelial function and blood pressure

Slides (presentation) - Oct. 18, 2011

Prof. John Deanfield
University College London
United Kingdom

To view presentation, click on slides below

De-risking the development programs of CETP inhibitors after the torcetrapib failure: Endothelial function & blood pressure
HDL : a novel target in prevention ?
Relationship Between Changes in LDL-C and HDL-C Levels and CHD Risk
Coronary Heart Disease and HDL-C
Reduced HDL is associated with increased CV risk – despite intense statin therapy
HDL-Raising Therapies on the Horizon
Schematic Overview of Lipoprotein Metabolism
Torcetrapib in High-risk Patients : ILLUMINATE Study
Torcetrapib causes Endothelial Dysfunction independent of CETP inhibition
CETP Inhibition and Endothelial Function
dal-VESSEL : Study Design
dal-Vessel: ABPM
dal-Vessel: baseline FMD
HDL as a Therapeutic Target

Download teaching slides

Share this page with your colleagues and friends: